ASPN vs LEN · rev $452.7M vs rev $34.19B
Aspen Aerogels Inc (ASPN) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Aspen Aerogels Inc (ASPN) is a building products & equipment company listed on US.
LEN (LEN) common stock.
Latest reported ASPN revenue for 2024-12-31 was $452.7M. Net income was $13.4M. Revenue was up 89.6% from 2023-12-31 to 2024-12-31. ASPN currently screens at market cap $515.5M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
ASPN currently screens at market cap $515.5M. LEN currently screens at market cap $0.
Not investment advice. Open the ASPN and LEN stock pages for the full models.
Not investment advice.